Verrica Pharmaceuticals Inc (NASDAQ:VRCA)
| 6.22 Delayed Data As of Aug 13 |  +0.11 / +1.79%Today’s Change | 6.02 Today|||52-Week Range 18.67 | -60.86% Year-to-Date |
Latest VRCA News | Press Releases
| Verrica Pharmaceuticals: A Long Haul Ahead Before An FDA Approval Jul 30 / Seeking Alpha - Paid Partner Content | Arcutis Biotherapeutics appoints Verrica Pharma's CMO Jul 27 / Seeking Alpha - Paid Partner Content |
| Verrica Pharmaceuticals: The Fundamentals Aren't So Clear, But The Stock Chart May Be Telling Us Something Jul 30 / Seeking Alpha - Paid Partner Content | Arcutis Biotherapeutics names new CMO Jul 27 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 6.16 |
| Today’s open | 6.27 |
| Day’s range | 6.16 - 6.55 |
| Volume | 383,116 |
| Average volume (3 months) | 112,667 |
| Market cap | $173.5M |
Data as of 3:59pm ET, 08/13/2020
Growth & Valuation
| Earnings growth (last year) | +19.55% |
| Earnings growth (this year) | -44.84% |
| Earnings growth (next 5 years) | -20.18% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.65 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OTICOtonomy Inc | +0.08 | +2.42% |
| HROWHarrow Health Inc | -0.17 | -2.69% |
| AYTUAytu BioScience Inc | -0.02 | -1.53% |
| MTNBMatinas BioPharma Ho... | +0.00 | +0.01% |
Data as of 3:59pm ET, 08/13/2020
Financials
| Next reporting date | November 4, 2020 |
| EPS forecast (this quarter) | -$0.43 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$28.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters West Chester, Pennsylvania |
Forecasts
